Cargando…

Microarray technology and its effect on breast cancer (re)classification and prediction of outcome

Detalles Bibliográficos
Autor principal:	Cardoso, Fatima
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314420/ https://www.ncbi.nlm.nih.gov/pubmed/14580246

Ejemplares similares

Re-evaluating early breast neoplasia
por: Moulis, Sharon, et al.
Publicado: (2008)

PERFICT: A Re‐imagined foundation for predictive ecology
por: McIntire, Eliot J. B., et al.
Publicado: (2022)

Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment
por: Teo, Wei Wen, et al.
Publicado: (2014)

A classification of the aims of vaccination and its relevance to transgenerational justice
por: Atzinger, Lea, et al.
Publicado: (2020)

Incessant ovulation and ovarian cancer – a hypothesis re-visited
por: Fathalla, M.F.
Publicado: (2013)

Determining sensitivity to rapamycin and its analogues in breast cancer patients
por: Witton, Caroline J
Publicado: (2005)

Reconstructing Re‐emergent Tremor
por: Swinnen, Bart E.K.S., et al.
Publicado: (2023)

Potential Uses of Blockchain Technology for Outcomes Research on Opioids
por: Gonzales, Aldren, et al.
Publicado: (2021)

Show me the genes – I will tell you who/how to treat!
por: Cardoso, Fatima
Publicado: (2005)

Re-thinking health inequalities is necessary
por: Mackenbach, Johan P
Publicado: (2020)

Measuring the Implementation of Behavioral Intervention Technologies: Recharacterization of Established Outcomes
por: Hermes, Eric DA, et al.
Publicado: (2019)

Evaluating Patient-Centered Mobile Health Technologies: Definitions, Methodologies, and Outcomes
por: Bruce, Courtenay, et al.
Publicado: (2020)

Proposed Genetic Classification for the Skin Types: Helmy’s Skin Types Classification
por: Ali, Yaaser Helmy
Publicado: (2019)

Ethical Implications of the Use of Language Analysis Technologies for the Diagnosis and Prediction of Psychiatric Disorders
por: Loch, Alexandre Andrade, et al.
Publicado: (2022)

Artificial intelligence-based prediction for cancer-related outcomes in Africa: Status and potential refinements
por: Adeoye, John, et al.
Publicado: (2022)

High Definition Liposuction Classification
por: Vera Cucchiaro, Javier
Publicado: (2019)

Emerging Technologies for Cancer Prevention and Other Population Health Challenges
por: Eng, Thomas R
Publicado: (2005)

African perspectives: modern complexities of emerging, re-emerging, and endemic zoonoses
por: Muzemil, Abdulazeez, et al.
Publicado: (2018)

“Doctor, You’re COVID (+)”: Twenty Next Steps for Plastic Surgeons
por: Bentz, Michael L.
Publicado: (2020)

Re-examining the HIV ‘functional cure’ oxymoron: Time for precise terminology?
por: Dubé, Karine, et al.
Publicado: (2020)

Graft injury and re-transplantation in liver transplant patients with COVID-19
por: Ng, Alexander
Publicado: (2021)

Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto
por: Cardoso, Fatima, et al.
Publicado: (2021)

The molecular classification of hereditary endocrine diseases
por: Ye, Lei, et al.
Publicado: (2015)

Defeating re-emerging Alkhurma hemorrhagic fever virus outbreak in Saudi Arabia and worldwide
por: Tambo, Ernest, et al.
Publicado: (2018)

Re-Testing Patients for COVID-19 after Symptomatic Recovery: a Work in Progress
por: Campion Dialo, Nicole, et al.
Publicado: (2020)

Preventing Emerging and Re-emerging Infections in the Eastern Mediterranean Region: Gaps, Challenges, and Priorities
por: Araj, Rawan, et al.
Publicado: (2019)

How to recognize and respond to viral re-positivity and disease relapse in patients with COVID-19
por: Zheng, Shiliang, et al.
Publicado: (2021)

Cultural Responsivity in Technology-Enabled Services: Integrating Culture Into Technology and Service Components
por: Eustis, Elizabeth H, et al.
Publicado: (2023)

mHealth Apps as Effective Persuasive Health Technology: Contextualizing the “Necessary” Functionalities
por: McLean, Allen
Publicado: (2020)

Real-World Clinical and Economic Outcomes Associated with Palbociclib for HR-Positive/HER2 Negative Metastatic Breast Cancer: A Commentary
por: Babcock, Aram, et al.
Publicado: (2020)

A prophylactic vaccine for breast cancer?
por: Watson, Christine J, et al.
Publicado: (2010)

Are breast cancers driven by fusion genes?
por: Edwards, Paul AW, et al.
Publicado: (2012)

Pathological Model of Hemangioma—New Thinking on Hemangioma Classification
por: Xu, Zundi
Publicado: (2016)

Heart failure classification in clinical practice: time to redefine?
por: Hu, Kai, et al.
Publicado: (2022)

The Emergence of Personalized Health Technology
por: Allen, Luke Nelson, et al.
Publicado: (2016)

Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term
por: Jankowitz, Rachel C, et al.
Publicado: (2012)

The Behavioral Intervention Technology Model: An Integrated Conceptual and Technological Framework for eHealth and mHealth Interventions
por: Mohr, David C, et al.
Publicado: (2014)

Is Artificial Intelligence Better Than Human Clinicians in Predicting Patient Outcomes?
por: Lee, Joon
Publicado: (2020)

Amping up estrogen receptors in breast cancer
por: Fowler, Amy M, et al.
Publicado: (2007)

Introducing the concept of breast cancer stem cells
por: Waterworth, Alison
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_hvi4adq4dqccf67t537bu9rrm3